Exclusive Interview with Cedric Gysel Johnson and Johnson’s Cedric Gysel for Pre-Filled Syringe and Injectable Drug Devices 2020 Read more
Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharma Following Positive Phase 2a Proof-of-Concept Study Read more
Biogen Plans Regulatory Filing for Aducanumab in Alzheimer’s Disease Based on New Analysis of Larger Dataset from Phase 3 Studies Read more
Odonate Therapeutics announces completion of enrollment in CONTESSA metastatic breast cancer trial Read more
Knight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth Platform Read more